ArticleFrontiers in immunology2025

Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter cohort study.

Na Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.